Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The pancreatic cancer trial record is displayed, with details on study status, eligibility, treatments, outcome measures, locations, and record dates, along with a study protocol document. It replaces the previous error page.
    Difference
    51%
    Check dated 2026-11-08T05:12:26.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record area now shows a 403 Forbidden message and a Home button. The site footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-01T02:04:04.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning its terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:04:31.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:53:45.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:20:48.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual study details with an access-block message.
    Difference
    19%
    Check dated 2026-09-20T01:09:50.000Z thumbnail image

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.